key: cord-0860369-bjzxsw8a
authors: Ranjan, R.; Sharma, A.; Verma, M. K.
title: Characterization of the Second Wave of COVID-19 in India
date: 2021-04-21
journal: nan
DOI: 10.1101/2021.04.17.21255665
sha: 319738b169f0ea347a087e95cc49f34b5e8f329c
doc_id: 860369
cord_uid: bjzxsw8a

Background: The second wave of COVID-19 is affecting most of the world. The scenario is very grim in India where the daily count on April 15, 2021 itself is double of the first peak. The epidemic evolution there is quite complex due to regional inhomogeneities. In this paper, we characterize the virus spread in the ongoing second wave in India, as well as study the dynamical evolution of epidemic from the beginning of the pandemic. Methods: Variations in the effective reproduction number (Rt) in India are taken as a quantifiable measure of the virus transmissibility and are compared with those of other countries where the second wave is already over. Further, characteristics of COVID-19 spread are analyzed for Indian states by estimating test positivity and case fatality rates. Finally, forecasts and actionable inputs are provided based on mathematical and epidemiological models. Results: Effective reproduction number for almost every state in India has value greater than 1 indicating the presence of the second wave. An exponential fit on recent data indicates that the infection rate is much higher than the first wave however the case fatality rate is lower. Preliminary estimates with the SIR model suggest the peak for the second wave to occur in mid-May 2021 with daily count exceeding 0.35 million. Conclusions: The spread of the second wave is much faster than the first wave. Hence, quick and effective administrative intervention is needed to arrest the rapid growth of the epidemic.

More than one year since COVID-19 was declared a pandemic on March 11, 2020, by World Health Organization (WHO), the deadly SARS-CoV-2 virus continues to disrupt public life across the world. Although the lockdown norms are relaxed in most places, social life is still far from normal. Recently, multiple vaccines developed by Oxford-AstraZeneca (Covishield/Vaxzevria), Pfizer-BioNTech (Comirnaty), Moderna, Johnson & Johnson's Janssen, Bharat Biotech (Covaxin), Gamaleya Research Institute of Epidemiology and Microbiology (Sputnik V) etc. have been approved in several countries and are given on priority to susceptible populations and those with co-morbidities. However, the production and distribution of vaccines at a massive scale to cover a very large population remain a formidable challenge. Meanwhile, in order to arrest the spread of the virus during the vaccination drive, intervention measures such as wearing masks, social distancing guidelines, partial lockdowns, and restricted store hours are still in place in most places.

While nations are taking extensive measures to accelerate the vaccination drive in order to control the pandemic at the earliest, a public health challenge has appeared due to mutations of the SARS-CoV-2 virus which make it highly contagious. For example, the SARS-CoV-2 lineage B.1.1.7, which was first detected in the United Kingdom (UK) in November 2020, is estimated to be 40-80% more transmissible than the wild type SARS-CoV-2 (Davies et al 2021; Volz et al 2021) . Similarly, strains from South Africa (B.1.351), Brazil (P.1), and India (B.1.617) are also significantly more contagious (Chen et al 2020) than the variants in early 2020. There is no clear evidence on severity of the new mutations (Davies et al 2021) , however the challenge is to prepare for health response especially when the number of infections is exceedingly large. Figure 1 (a,b) shows the temporal variations of daily COVID-19 cases and deaths in the top six countries which are most affected in terms of the maximum number of cumulative cases as of April 14, 2021. The data has been taken from the repository maintained by 'Our World in Data'. Among the countries shown, the United States (US) has maximum cumulative cases with a total of about 32 million, followed by India that has 14 million cases. Although if we compare the epidemic growth in these countries as shown in the figure, India recently has almost tripled the number of daily cases compared to the US. The plot also shows the peaks of the first and second waves in different countries where they were observed. The US, for example, had the first peak in mid-July 2020 following which the cases subsided. However, the infection counts started increasing in October and a much larger peak in the second wave in December 2020 with daily cases of up to 0.25 million. In the UK, the first and second peaks were separated by only a couple of months with the second wave largely attributed to a more infectious mutant (Leung et al 2021) . For Russia, the infection curve is relatively shallower with the number of daily cases never crossing 30,000. In the curve for Brazil, there are large fluctuations which may be due to insufficient testing, however the number of deaths per infection (typically called Case Fatality Rate (CFR)) is very large, as can be inferred from figure 1(b). The curve for the death cases typically follows the infections. Note however that the CFR was very high at the beginning of the pandemic (around April 2020) for the US and European countries (Borghesi et al 2021) .

For India, as seen in figures 1(a) and (b), the first and second waves are separated by about 5 months. The peak of the first wave was in September 2020 with the daily cases of around 0.1 million. The daily cases decreased until mid-February after which it exhibited a sharp increase. The end of the first wave was likely a result of a combination of factors -effective implementation of government interventions, increase in awareness, and, most importantly, the experience gained by medical professionals in treating the disease over the initial months. On April 15, 2021, the number of new cases was about 0.2 million which is already more than double of the first peak value. The sudden surge in the number of cases after a relatively long 'cooling' time is baffling although it may be attributed to highly infectious double mutant variant of SARS-CoV-2 (B.1.617 lineage), to negligent behaviour of the population, and to the relaxation of interventions (Xu and Li 2020) . The number of daily deaths is also rising recently, but the CFR is low compared to the first wave; this aspect will be further discussed later. Note that the study on B.1.617 mutant is limited and there is no clear evidence on whether the mutant virus is less severe than its predecessor.

We also look at the regional distribution of COVID-19 spread to further characterize the second wave. Figure 2 (a,b) shows the daily numbers of cases in 16 key states in India in linear and log scales respectively. In figure 2(a), we note that all the states are showing a surge in the number of cases since 13 February, 2021. Further, the slopes of the growth curve are very high in the second wave compared to the first. The daily number of cases in Maharashtra, which also leads in the daily as well as cumulative infections, went from daily cases of 652 on Feb 11, 2021 to about 63,000 in two months (as on April 11, 2021) . This exponential growth is also observed in other states (see figure 2(b)), albeit the number of daily cases is fewer than that in Maharashtra. The growth curve in the second wave can be further divided into relatively slow and fast growth . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 21, 2021. ; https://doi.org/10.1101/2021.04.17.21255665 doi: medRxiv preprint At the outset, the second wave in India looks much more precarious than the first wave and the situation could quickly get out of control unless stringent measures are taken. The vaccination drive need to be enhanced to include more vaccine candidates spread over younger population, say up to 25 years of age. However considering the large population of India and the current spread of the virus mutants into remote locations of India (discussed later), these strategies may not be sufficient to stem the spread of the virus. The purpose of this paper is to characterize and model the second wave so as to create awareness about the present grim situation and also sensitize the public about the need for social distancing. We also use the data to make informed projections of the epidemic growth based on an epidemiological model.

The present study is based on COVID-19 data from the beginning of the pandemic to April 15, 2021. COVID-19 data for countries around the globe and Indian regional states are respectively taken from repositories maintained by ourworldindata (OWID) and covid19india.org. OWID compiles data from the European Centre for Disease Prevention and Control (ECDC).

In order to identify the first and second waves, we study the effective Reproduction number (R t ; Fraser et al (2004)) as a marker for the decrease or surge in infections. R t provides real-time feedback on the spread of pandemic as the R t > 1 indicates a growth in infection, thus the goal is to implement social interventions to bring down R t below 1 and close to 0 as much as possible. Time-varying R t can be calculated using time series of the infections and generation time distribution (Cori et al 2013) . We use the approach developed by Thompson et al (2019) for the estimation of effective Reproduction numbers using the R-package EpiEstim. A MATLAB implementation of this package, developed by Batista (2021) , is used for the current study. The generation time distribution requires serial interval as an input, which indicates the time between the onset of symptoms of a primary case and the onset of symptoms of secondary cases. Several studies (Du et al 2020; Knight and Mishra 2020; Rai et al 2020; Nishiura et al 2020) have estimated serial interval for COVID-19. We . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 21, 2021. take the mean serial interval as 4.7 days (95% Credible Interval [CI]: 3.7, 6.0) with the standard deviation (SD) of the serial interval as 2.9 days (95% CI: 1.9, 4.9) based on Nishiura et al (2020). The available dataset for the second wave has also been used for the predictions using the popular compartmental Susceptible-Infected-Recovered (SIR) model (Hethcote 2000) . The incidence data between 13 February 2021 and 13 April 2021 have been used for best-fit functions. Note that the pandemic is still in the exponentialgrowth phase, as further expanded in the next section. Therefore, there is large uncertainty in the estimation of the peak of the daily cases, as well as the duration of the second wave. The details about the implementation of SIR model are given in Ranjan (2020a) .

Figure 3 exhibits the daily confirmed cases of COVID-19 and R t in India. The effective reproduction number trend is commensurate with the infection rate as shown in the panel below. The R t value decreased from about 1.37 (95% CI 1.25-1.52) on 17 April 2020 to 1.09 (95% CI 1.07-1.11) on 10 September 2020. R t went below the self-sustaining threshold of 1 for the first time on 23 Sep 2020 and remained there for the next 5 months, except for a minor flare up on 29 Nov for a couple of days. After this relatively long quiet interval, R t started rising on 19 February 2021, which is taken as the arrival date for the second wave in India. The R t has been increasing since then; as on April 15, 2021, R t has reached approximately 1.37 (95% CI 1.28-1.47).

In figure 4 we exhibit region-wise variations of the effective reproduction numbers for most-impacted states as on April 15, 2021, while the most recent value of R t for all the states are reported in table 1. As evident in the figure, R t curve crossed the threshold first in Maharashtra and about a week later in other states. However, very recently there has been a slight decline in the R t value in Maharashtra (and also in Chhatisgarh). States like Uttar Pradesh and Delhi are in high growth phase with R t values as 1.97 and 1.79 respectively. The incidence curves for these states show that the current daily cases are already higher than that of the first peak except for Andhra Pradesh and Kerala.

All the states (except Nagaland) in India (see Table 1 ) has R t > 1 indicating the arrival of the second wave. It appears that mutant viruses are playing some role in the second wave. A more concerning fact is that some of the most-populated states such as Uttar Pradesh and Bihar, which were some of the least impacted states during the first wave, now show very high reproduction numbers. Note that there is a large rural population in these states where the healthcare system is inadequate for such a scale of pandemic. With the spread of . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 21, 2021. the virus in these remote and rural areas, an effective administrative intervention is required to minimize the impact of the pandemic.

In table 2, we list the R t values for the most impacted countries on April 14, 2021. Except for UK, where the pandemic is in decline (R t 0.82), the other four countries have R t close to the threshold value. The vaccinated population per 100 persons is also listed in the table. Among all countries, the US and UK have the highest vaccinations per 100 persons; these countries are possibly least susceptible to another wave provided the vaccines can provide protection against change in virus phenotype due to mutations (Grubaugh et al 2020) .

To further characterize the second wave, we employ the following well-known ratios:

Case Fatality Rate (CFR) = Total deaths Total infections Figure 5 illustrates the temporal variations of these parameters for the first and second waves. The Test positivity rate (TPR) typically indicates whether the number of tests is enough to contain the spread of the virus by isolating and quarantining the positive cases. WHO recommends that the TPR value should be less than 5% for effective implementation of healthcare programs. India shows an increase in TPR during the acceleration phase of the first wave and it starts declining from August 2020. Recently, the TPR curve shows an upward trend commensurate with the spurt of cases, with a TPR value of 5.4% as on April 14, 2021, suggesting that the testing needs to be ramped up. Further, there are large variations among different regions in India as shown in Table 1 . Maharashtra has a very high TPR of 15.7% indicating very high transmission and, therefore, the actual number of infections is likely to be higher than that being reported due to a limited diagnostics.

Next, we report the case fatality rate for India in figure 5 . The CFR curve shows a downward trend -from 3.5% in mid-April 2020 to 1.2% in mid-April 2021 with minor fluctuations. Interestingly, although the second wave shows the virus to be more infectious, the decline in the CFR curve suggests a silver lining of a relatively less fatal mutant. However, considering an exponential increase of cases at a very high rate, it is expected that . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 21, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 soon the healthcare facilities will be fully throttled resulting in the unavailability of hospital beds and ventilators to those in critical needs. This may result in an increase in CFR. Even otherwise, in terms of absolute numbers, the daily deaths are already at the level of peak values in the first wave (see figure 1(b) ). Table 1 lists statewise data of CFR, with Punjab having the highest value and Kerala the least among severely-affected states. Finally we describe the vaccination data in states as listed in Table 1 . Among the most-impacted states with sizeable population, Kerala and Chhatishgarh have highest vaccination per 100 people. Uttar Pradesh and Bihar, which have very high R t , have the lowest level of vaccination per capita. This further suggests the need for strong lockdown measures in the North Indian states while vaccination capacity is increased simultaneously.

After characterization of the second wave, we employ mathematical and epidemiological models to understand the dynamics and to provide actionable insights. As discussed earlier (see figure 2) , the second wave started slowly near 11 February 2021 in Maharashtra and Punjab, but the epidemic spread quite rapidly in other states from early March. Therefore we use two exponential curves to fit the incidence (daily cases) data. Further, we compare this fit with that of the first wave, starting from a date when the number of infections was similar to that in the second wave. Figure 6 exhibits these exponential fits, while the coefficients as well as statistical fitness data are listed in Table 3 . The first exponential fit of the second wave has a lower exponent than the first wave (compare b 1 and b 2 in table 3), although it has relatively low value of the co-efficient of determination (adjusted R 2 0.62). However, the exponent of the second fit on more recent data in the second wave is more than twice of the first wave that explains the rapid growth of the pandemic. Fits for both the first wave and rapid second wave are statistically significant with adjusted R 2 greater than 0.95.

We now employ the popular SIR model for an approximate prediction of the progression of the pandemic as it takes both the incidence and recovery data to estimate the peak and eventual decline. Note that an accurate estimation with SIR typically requires data beyond exponential growth (such as power-law variation (Asad . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 21, 2021. ; https://doi.org/10.1101/2021.04.17.21255665 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 21, 2021. et al 2020; Verma et al 2020) ). Nonetheless, the results presented below should be taken as an approximate scenario in terms of case count, provided no new interventions are introduced. This will help policymakers to prepare for the future and plan necessary actions. Figure 7 shows the predictions using the data between 19 February 2021 and 13 April 2021. Based on this model, the peak of the second wave is estimated in the middle of May with the peak number of daily cases of about 0.36 million. Furthermore, even with a low CFR of 1.2% . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 21, 2021. ; https://doi.org/10.1101/2021.04.17.21255665 doi: medRxiv preprint as of April 14, 2021, India will have about 4,500 deaths per day at its peak. Note that SIR model may not be very accurate because it does not include many factors such as asymtomatic patients, lockdowns, vaccination, etc. However, accurate modelling of the second wave will require more data, which is not available at present. We plan to employ universal curve (Sharma et al 2021) and refined epidemiological models (Ranjan 2020b) for improved prediction of the second wave in India. 

The second COVID-19 wave in India, which began on February 11, 2021, presents a grim situation as the number of cases crossed 0.2 million a day on April 14, 2021. The data suggests that at present the virus is much more infectious than the first wave, but the number of daily deaths per infection is lower. However, with an inordinate increase in the number of cases and over-stretched healthcare system, the daily death count may increase substantially. The effective reproduction number (R t ) is estimated for India, as well as for the Indian states. At present, almost every state show R t > 1 suggesting that the second wave has spread everywhere including rural areas which were largely untouched during the first wave. This includes populous states like Uttar Pradesh, Bihar, and West Bengal: each has R t value greater than 1.68. With rural areas impacted, it may be necessary to take aggressive lockdown measures to arrest the further spread while sufficient amount of vaccine becomes available. The SIR model suggests the peak of the epidemic to occur in the middle of May 2021 with approximate daily infections exceeding 0.35 million.

In summary, using the available infection data, we analyze the second COVID-19 wave in India. We observe that the epidemic is creating unprecedented havoc in the population. We hope that the appropriate administrative intervention, aggressive vaccination drive, and people's participation will help flatten the curve earlier than the grim forecast of the epidemic.

The authors declare that they have no conflict of interest.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 21, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 

Evolution of covid-19 pandemic in india

2021) estimate r, matlab central file exchange

Covid-19 second wave less severe and deadly than the first? a preliminary investigation

Mutations strengthened sars-cov-2 infectivity

A new framework and software to estimate time-varying reproduction numbers during epidemics

Estimated transmissibility and impact of sars-cov-2 lineage b. 1.1. 7 in england

Serial interval of covid-19 among publicly reported confirmed cases

Factors that make an infectious disease outbreak controllable

Making sense of mutation: what d614g means for the covid-19 pandemic remains unclear

The mathematics of infectious diseases

Estimating effective reproduction number using generation time versus serial interval, with application to covid-19 in the greater toronto area

Early transmissibility assessment of the n501y mutant strains of sars-cov-2 in the united kingdom

Serial interval of novel coronavirus (covid-19) infections

Estimates of serial interval for covid-19: A systematic review and meta-analysis

Predictions for COVID-19 outbreak in India using epidemiological models

Temporal dynamics of COVID-19 outbreak and future projections: A data-driven approach

Universal epidemic curve for covid-19 and its usage for forecasting

Improved inference of time-varying reproduction numbers during infectious disease outbreaks

COVID-19 pandemic: Power law spread and flattening of the curve

Assessing transmissibility of sars-cov-2 lineage b. 1.1. 7 in england

Beware of the second wave of covid-19